These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26394517)

  • 21. Pharmacologic approaches to the management of alcoholism.
    Anton RF
    J Clin Psychiatry; 2001; 62 Suppl 20():11-7. PubMed ID: 11584870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of drugs for alcohol use disorder in Norway 2004–16].
    Heldal AT; Skurtveit S; Lobmaier PPK; Vederhus JK; Bramness JG
    Tidsskr Nor Laegeforen; 2018 Nov; 138(18):. PubMed ID: 30421743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alcohol dependence: after the withdrawal phase. Long-term abstinence: better health and psychosocial status. Psychosocial support for a chronic disorder. Some drugs are useful adjuncts to medical support.
    Prescrire Int; 2009 Oct; 18(103):222-3. PubMed ID: 19882797
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pharmacological relapse prevention in alcohol and tobacco dependence].
    Diehl A; Mann K
    Internist (Berl); 2007 Jan; 48(1):79-84, 86-8. PubMed ID: 17122900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naltrexone and acamprosate. Using new drugs for alcohol dependence.
    Tedeschi M
    Aust Fam Physician; 2001 May; 30(5):447-50. PubMed ID: 11432017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial.
    Martinotti G; Di Nicola M; Tedeschi D; Andreoli S; Reina D; Pomponi M; Mazza M; Romanelli R; Moroni N; De Filippis R; Di Giannantonio M; Pozzi G; Bria P; Janiri L
    J Psychopharmacol; 2010 Sep; 24(9):1367-74. PubMed ID: 19346279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New treatment options for alcohol dependence].
    Müller CA; Heinz A
    MMW Fortschr Med; 2013 May; 155(8):63-5. PubMed ID: 24437142
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of alcohol dependence: recent progress and reduction of consumption.
    Testino G; Leone S; Borro P
    Minerva Med; 2014 Dec; 105(6):447-66. PubMed ID: 25392958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacotherapy of alcohol dependence: a review of the clinical data.
    Mann K
    CNS Drugs; 2004; 18(8):485-504. PubMed ID: 15182219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
    Morley KC; Teesson M; Reid SC; Sannibale C; Thomson C; Phung N; Weltman M; Bell JR; Richardson K; Haber PS
    Addiction; 2006 Oct; 101(10):1451-62. PubMed ID: 16968347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenetics of alcohol use disorders and comorbid psychiatric disorders.
    Helton SG; Lohoff FW
    Psychiatry Res; 2015 Dec; 230(2):121-9. PubMed ID: 26455758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alcohol dependence: analysis of factors associated with retention of patients in outpatient treatment.
    Fonsi Elbreder M; de Souza e Silva R; Pillon SC; Laranjeira R
    Alcohol Alcohol; 2011; 46(1):74-6. PubMed ID: 21118901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacotherapy for alcohol dependence: status of current treatments.
    Franck J; Jayaram-Lindström N
    Curr Opin Neurobiol; 2013 Aug; 23(4):692-9. PubMed ID: 23810221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alcohol use disorders in pregnancy.
    DeVido J; Bogunovic O; Weiss RD
    Harv Rev Psychiatry; 2015; 23(2):112-21. PubMed ID: 25747924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medications for treating alcohol dependence.
    Williams SH
    Am Fam Physician; 2005 Nov; 72(9):1775-80. PubMed ID: 16300039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
    Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
    Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medicaid coverage of medications to treat alcohol and opioid dependence.
    Mark TL; Lubran R; McCance-Katz EF; Chalk M; Richardson J
    J Subst Abuse Treat; 2015 Aug; 55():1-5. PubMed ID: 25921475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substance abuse and schizophrenia: pharmacotherapeutic intervention.
    Green AI; Noordsy DL; Brunette MF; O'Keefe C
    J Subst Abuse Treat; 2008 Jan; 34(1):61-71. PubMed ID: 17574793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects.
    Staner L; Boeijinga P; Danel T; Gendre I; Muzet M; Landron F; Luthringer R
    Alcohol Clin Exp Res; 2006 Sep; 30(9):1492-9. PubMed ID: 16930211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acamprosate for the treatment of alcohol dependence.
    Boothby LA; Doering PL
    Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.